Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4,205 JPY | +2.51% | +1.94% | +3.72% |
04:06pm | Scilex Holding Says Federal Court Approved Settlement With Takeda Pharmaceutical in Gloperba Patent Dispute | MT |
05-13 | Sector Update: Health Care Stocks Mixed Late Afternoon | MT |
Sales 2024 | 4,264B 27.26B 37.18B | Sales 2025 * | 4,070B 26.03B 35.5B | Capitalization | 6,436B 41.15B 56.13B |
---|---|---|---|---|---|
Net income 2024 | 144B 921M 1.26B | Net income 2025 * | 155B 993M 1.35B | EV / Sales 2024 | 1.54 x |
Net Debt 2024 * | 3,771B 24.11B 32.88B | Net Debt 2025 * | 4,027B 25.75B 35.12B | EV / Sales 2025 * | 2.57 x |
P/E ratio 2024 |
45.4
x | P/E ratio 2025 * |
40.4
x | Employees | 49,095 |
Yield 2024 * |
4.58% | Yield 2025 * |
4.65% | Free-Float | 99.12% |
Latest transcript on Takeda Pharmaceutical Company Limited
1 day | +2.51% | ||
1 week | +1.94% | ||
Current month | +1.25% | ||
1 month | +1.42% | ||
3 months | -3.33% | ||
6 months | +1.79% | ||
Current year | +3.72% |
Managers | Title | Age | Since |
---|---|---|---|
Christophe Weber
CEO | Chief Executive Officer | 57 | 14-03-31 |
Gabriele Ricci
CTO | Chief Tech/Sci/R&D Officer | 45 | 22-01-31 |
Mwana Lugogo
CMP | Compliance Officer | 54 | 11-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 71 | 16-05-31 | |
Ian Clark
BRD | Director/Board Member | 62 | 18-12-31 |
Steven Gillis
BRD | Director/Board Member | 71 | 18-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
24.44% | 19 M€ | +11.67% | ||
5.00% | 288 M€ | +23.71% | ||
3.80% | 1,531 M€ | +20.59% | ||
3.43% | 240 M€ | +15.33% | ||
3.26% | 60 M€ | +20.57% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-14 | 4,205 | +2.51% | 5 511 800 |
24-05-13 | 4,102 | -0.65% | 5,677,600 |
24-05-10 | 4,129 | +1.45% | 8,275,700 |
24-05-09 | 4,070 | +0.42% | 3,465,100 |
24-05-08 | 4,053 | -1.12% | 5,332,100 |
Delayed Quote Japan Exchange, May 14, 2024 at 02:00 am
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.72% | 41.2B | |
+29.61% | 682B | |
+30.35% | 586B | |
-3.62% | 364B | |
+17.71% | 327B | |
+3.85% | 285B | |
+15.74% | 240B | |
+10.32% | 209B | |
-8.38% | 203B | |
+7.12% | 165B |
- Stock Market
- Equities
- 4502 Stock